Mewburn Ellis

We are thrilled to announce we have been officially named as a Great Place To Work™ 2024 by Great Place To Work UK®. Not only are we the only IP firm in the UK to be recognised so far, we are also the first European IP firm to earn this accreditation. This is testament to our stance on inclusivity and a collaborative culture where employees are prioritised first. Thank you to all our wonderful employees for making Mewburn Ellis a #GreatPlaceToWork. You can read more about this here: https://hubs.la/Q02zPjj70 #GreatPlaceToWork #EmployeeExperience #WorkCulture

Following on from the recent webinar on the latest research in sports gynae health run by Hertility, Alice Jefferies explores the challenges of optimising the female athletic performance, and highlights the incredible innovation that is striving for answers. Read more here - https://hubs.la/Q02MkRJr0 #femtech #medtech #mewburnmedtech #mewburnfemtech #AI

Antibody-drug conjugates (ADCs) are big business. Big pharma is moving in, snapping up companies or licensing their technology; Pfizer, Merck and Johnson & Johnson are among those to have struck billion-dollar deals in the ADC space. And, with the global market in the cancer drugs topping $10bn for the first time last year – and forecast to reach almost $30bn by 2028 – it is little wonder that analysts have described ADCs as the ‘hottest real estate in oncology’. Forward spoke to Patrick van Berkel, ADC Therapeutics Chief Scientific Officer, on why there is such excitement around the ADC modality. Read the full Forward Feature: https://lnkd.in/eamfDTHy #AntibodyDrugConjugates #TherapeuticModality #CancerTreatment #MewburnLifeSciences #MewburnAntigenBindingMolecules

Featuring in the CIPA Journal, Sean Jauss PhD and Matthew Naylor explain how protective letters can be an effective tool to discourage an applicant from pursing an application for a preliminary injunction at the Unitary Patent Court. However, it needs to be prepared carefully and thoughtfully, and it should not simply re-hash arguments previously rejected by other courts or the European Patent Office. Read the full article here - https://hubs.la/Q02M2Mw_0 #MewburnUPC #UPC #ProtectiveLetters #CIPA

The critical, yet delicate balance of the microbiome in maintaining health and influencing disease is becoming increasingly recognised. Alice Jefferies explores recent research that has established critical links between gut bacterial metabolites and diseases such as chronic liver disease and Alzheimer’s - https://hubs.la/Q02M1CF10 #mewburnmicrobiome #mewburnsyntheticbiology #microbiome #syntheticbiology

Today marks #WorldEntrepreneursDay, and we are highlighting 5 key reasons why forward-looking SMEs prioritise IP. Intellectual property should be a core asset to any business, this is for both traditional protection of market position, but also for demonstrating innovation and branding. Without careful consideration of IP, SMEs risk losing out to competitors on one hand, and losing out on investment and growth opportunities on the other. Mewburn Ellis’ Special Report on the IP Guide for SMEs, looks at data in more detail, along with IP considerations for SMEs at all stages of their life cycle. You can read the full report here: https://hubs.la/Q02LWmPk0 #IP #IntellectualProperty #Entrepreneurs #SMEs

Eliot Ward is looking forward to attending the Co11ab anniversary event on 23 August 2023 in Singapore. Connect with Eliot – eliot.ward@mewburn.com #MewburnLifeSciences #MewburnSingapore #LifeSciences #BioTech #Singapore

As part of our commitment to the community, members of our London office have put together a team to walk the first quarter of the Thames Path Ultra Challenge on Saturday 14 September. They will walk 25KM along the river Thames from Putney to Hampton all in support of our London office’s chosen charity The National Brain Appeal. The National Brain Appeal is a charity who raises funds to support The National Hospital for Neurology & Neurosurgery and the UCL Queen Square Institute of Neurology – together known as Queen Square. This is one of the world’s leading centres for the diagnosis, treatment and care of patients with neurological and neuromuscular conditions. These include stroke, multiple sclerosis, brain cancer, epilepsy, Parkinson’s disease, and dementia. If you are able to support the team please click here to donate towards their fundraiser: https://hubs.la/Q02LSp7S0 #ThamesPathUltraChallenge #MewburnCharity Action Challenge

Featuring in Ship Technology & Ship Technology Global, David Brooks discusses the growth of battery-powered ships and the innovative battery tech being patented. https://hubs.la/Q02LJDmD0 #BatteryTech #ShipTechnology #OrganicFlowBatteries #MewburnChemistry #MewburnBatteries

Our WoMEn network here at Mewburn are passionate about giving back and supporting the community. One of our chosen charities we are supporting this year is Mothers for Mothers – a charity that offer maternal mental health and wellbeing support, advice and information to women, birthing people and their families. Mewburn is donating £7,500 to help Mothers for Mothers fund their work, continue to raise awareness of their life saving services and to reduce the stigma associated with Maternal Mental Health. Find out more here - https://lnkd.in/enbEAgTq #MothersforMothers #mewburncharity #maternalmentalhealth Mothers for Mothers - Bristol North Somerset South Glos